77-67-8
77-67-8
Chemical Structure
Ethosuximide
- CAS No.: 77-67-8
- Formula:C7H11NO2
- Molecular Weight:141.17
IUPAC Name: 3-ethyl-3-methylpyrrolidine-2,5-dione
InChIKey: HAPOVYFOVVWLRS-UHFFFAOYSA-N
SMILES: O=C(C(C)(CC)C1)NC1=O
Biological Activity: Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ethosuximide | 99.35% | Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide (Standard) | ≥98% | Ethosuximide (Standard) is the analytical standard of Ethosuximide. This product is intended for research and analytical applications. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-d3 | Ethosuximide-d3 is the deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-13C, d3 | Ethosuximide-13C, d3 is the 13C- and deuterium labeled Ethosuximide (HY-B1378). Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-d5 | Ethosuximide-d5 is deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
